This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Collin W G Fishwick: Innovator in β-lactamase Inhibitors
Introduction
Collin W G Fishwick is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of β-lactamase inhibitors. His work aims to enhance the effectiveness of antibiotics in treating tuberculosis and other infections.
Latest Patents
Collin holds a patent for the use of certain β-lactamase inhibitors in conjunction with one or more β-lactam antibiotics. This innovative approach is crucial for improving treatment outcomes for patients suffering from serious infections.
Career Highlights
Collin is associated with Oxford University Innovation Ltd, where he continues to advance his research and development efforts. His expertise in the field has positioned him as a key figure in pharmaceutical innovation.
Collaborations
He has collaborated with notable colleagues, including Samuel T Cahill and Jürgen Brem, to further enhance the impact of his research.
Conclusion
Collin W G Fishwick's contributions to the field of β-lactamase inhibitors represent a significant advancement in antibiotic treatment strategies. His work continues to influence the pharmaceutical landscape positively.